Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Vericel Corporation is a biopharmaceutical company specializing in advanced cell therapies for sports medicine and severe burn care. Its core products include FDA-approved autologous cell therapies MACI and Epicel, and the biologic NexoBrid licensed from MediWound. The company develops innovative biologic and tissue engineering solutions, serving orthopedic and burn treatment markets in the U.S., with a focus on improving patient outcomes and expanding minimally invasive procedures.
This description was generated via AI from an annual report. Updated about 1 year ago.